SpringWorks Therapeutics, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
7/10
|
21.09 | 57.27 | -63.17% | 4.7 | +348.64% |
| P/S |
|
13.98 | 33.44 | -58.19% |
|
|
| P/BV |
|
5.57 | 4.64 | 19.9% |
|
|
| P/FCF |
|
-9.72 | 42.53 | -122.85% |
|
|
| Ev/Ebitda |
|
-9.41 | -17.68 | -46.78% |
|
|
| Ev/S |
|
13.66 | 22.59 | -39.55% |
|
|
| Ev/FCF |
|
-14.53 | 47.55 | -130.57% |
|
|
| E/P |
|
-0.1475 | 0.0182 | -910.44% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-145.17 | -14.2 | 922.06% | -2282.95 | -93.64% |
| ROE |
|
-46.62 | 9.78 | -576.58% |
|
|
| ROA |
|
-39.32 | 0.33 | -12012.59% |
|
|
| ROIC |
|
-44.93 | 7.63 | -688.52% |
|
|
| ROS |
|
-134.73 | -26.41 | 410.08% |
|
|
| ROCE |
|
-71.3 | 14.5 | -591.66% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.0284 | -3.87 | -99.27% | -0.0208 | +37.04% |
| Nеt Debt/Ebitda |
|
0.2223 | -4.24 | -105.24% |
|
|
| Debt/Ratio |
|
0.0135 | 0.1853 | -92.73% |
|
|
| Debt/Equity |
|
0.0132 | 1.56 | -99.16% |
|
|
| Debt/Net Income |
|
-0.0307 | 10.06 | -100.3% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5351 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.7368 | -100% | ||
| DSI |
|
0 | 0.235 | -100% |
|
|
| Average dividend growth |
|
0 | 1.41 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.486 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.64 | -100% |
|
|
| Difference from average difference in sector |
|
-0.5351 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
10/10
|
447.4 | 30.62 | 1361.14% | ||
| Growth impulse Ebitda in 5 years |
|
504.63 | -17.42 | -2996.84% | ||
| Growth impulse Net Income in 5 years |
|
476.19 | -52.26 | -1011.19% | ||
| Growth impulse FCF in 5 years |
|
448.93 | -31.68 | -1517.08% | ||
| Growth impulse EPS in 5 years |
|
234.81 | -61.82 | -479.83% |
IP Score
4.88/10
